[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Azitra Inc (AZTR)

Azitra Inc (AZTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,428
  • Shares Outstanding, K 16,192
  • Annual Sales, $ 0 K
  • Annual Income, $ -10,960 K
  • EBIT $ -12 M
  • EBITDA $ -11 M
  • 60-Month Beta -1.29
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.34
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.10
  • Most Recent Earnings $-0.25 on 05/12/26
  • Next Earnings Date 08/10/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.21
  • Number of Estimates 1
  • High Estimate $-0.21
  • Low Estimate $-0.21
  • Prior Year $-0.18
  • Growth Rate Est. (year over year) -16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1735 +22.02%
on 05/14/26
0.2375 -10.86%
on 06/10/26
-0.0084 (-3.82%)
since 05/12/26
3-Month
0.1000 +111.70%
on 03/18/26
0.3799 -44.27%
on 03/20/26
+0.0317 (+17.61%)
since 03/12/26
52-Week
0.1000 +111.70%
on 03/18/26
2.3976 -91.17%
on 06/17/25
-1.6897 (-88.87%)
since 06/12/25

Most Recent Stories

More News
Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting

BRANFORD, Conn. , June 4, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology,...

AZTR : 0.2117 (-4.21%)
Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting

BRANFORD, Conn. , May 27, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology,...

AZTR : 0.2117 (-4.21%)
Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates

BRANFORD, Conn. , May 13, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies...

AZTR : 0.2117 (-4.21%)
Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program

Patent offers broad protections for ATR-12, an engineered strain of S. epidermidis that expresses a fragment of human LEKTI protein

AZTR : 0.2117 (-4.21%)
Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris

Preclinical data demonstrate ATR-01 delivers functional filaggrin, restoring skin barrier integrity and supporting advancement toward first-in-human studies

AZTR : 0.2117 (-4.21%)
Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million

Initial funding of approximately $10.5MM in convertible preferred stock and up to an additional $20.9MM upon cash exercise of warrants

AZTR : 0.2117 (-4.21%)
Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement

BRANFORD, Conn. , March 13, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology,...

AZTR : 0.2117 (-4.21%)
Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders

BRANFORD, Conn. , March 5, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR) ("Azitra" or the "Company") , a clinical stage biopharmaceutical company focused on developing innovative therapies...

AZTR : 0.2117 (-4.21%)
Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

BRANFORD, Conn. , Feb. 27, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision...

AZTR : 0.2117 (-4.21%)
Azitra, Inc. to Present at BIO Investment & Growth Summit

BRANFORD, Conn. , Feb. 19, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology,...

AZTR : 0.2117 (-4.21%)

Business Summary

Azitra Inc. is an early-stage clinical biopharmaceutical company. It focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. Azitra Inc. is based in BRANFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 0.2275
2nd Resistance Point 0.2243
1st Resistance Point 0.2180
Last Price 0.2117
1st Support Level 0.2085
2nd Support Level 0.2053
3rd Support Level 0.1990

See More

52-Week High 2.3976
Fibonacci 61.8% 1.5199
Fibonacci 50% 1.2488
Fibonacci 38.2% 0.9777
Last Price 0.2117
52-Week Low 0.1000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.